◀ Back to AKT2
AKT2 — HDAC4
Text-mined interactions from Literome
De Sarno et al., Neuropharmacology 2002
:
Two other inhibitors of
histone deacetylase , a recently identified target of sodium valproate, also
caused gradual increases in the phosphorylation of
Akt and GSK3beta
Chen et al., J Biol Chem 2005
:
Histone acetylation independent
effect of
histone deacetylase inhibitors on
Akt through the reshuffling of protein phosphatase 1 complexes
Lee et al., Mol Pharmacol 2008
:
Finally, activation of
Akt and CaM kinase II may eventually
lead to the acetylation of histone residues and phosphorylation of
histone deacetylase
Moskowitz et al., Curr Oncol Rep 2012
(Hodgkin Disease) :
Additional agents that have demonstrated activity in HL include
histone deacetylase inhibitors, such as panobinostat, entinostat, and mocetinostat,
PI3-kinase/Akt/Mtor pathway
inhibitors , such as everolimus, as well as lenalidomide and bendamustine